Results

Total Results: 1,088 records

Showing results for "cardiovascular".
Users also searched for: statin

121. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies … Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme … The TRANSCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular … ; CVD=cardiovascular disease; MI=myocardial infarction; PL=placebo; WDAE=withdrawals due to adverse … ARB therapy was associated with reductions in the composite endpoint of cardiovascular mortality,

122. Kidney-Disease-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
     October 01, 2012 - disease or the combination of diabetes and other cardiovascular risk factors. … Because even populations with a high CKD prevalence (e.g., diabetes, hypertension, cardiovascular … disease or diabetes combined with other cardiovascular risk factors (e.g., hypertension) and are … Renal outcomes in hypertensive Black patients at high cardiovascular risk. … disease or the combination of diabetes and other cardiovascular risk factors.

123. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
     April 11, 2011 - disease and mortality, accounting for an estimated 14 percent of cardiovascular deaths worldwide and … Outcomes:  Clinical outcomes (KQs 1a, 2, 3, and 4) o Cardiovascular events (myocardial infarction … o Cardiovascular disease mortality. o All-cause mortality. … We will extract basic demographic data such as age, sex, and race; diabetes, cardiovascular disease, … Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension

124. Comparative Effectiveness of Lipid-Modifying Agents | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/high-cholestorol-medications/research
     December 01, 2019 - Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular … Research Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular

125. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/ace-inhibitor-arb-2007/research-2007-1
     December 01, 2019 - blockers) for individuals with hypertension regarding their relative benefits (blood pressure control, cardiovascular … risk reduction, cardiovascular events, quality of life, and other outcomes), as well as relative risks

126. CER 5 Renal Artery Stenosis NSD SJ Clean (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
     June 24, 2014 - ), including blood pressure control, preservation of kidney function, flash pulmonary edema, other cardiovascular … rate of the composite primary end point or any of its individual components, including death from cardiovascular

127. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - Advances in antihypertensive therapy have dramatically reduced cardiovascular, cerebrovascular, and … and cerebrovascular events, incident diabetes or cardiovascular diagnoses, quality of life); and ( … risk reduction, cardiovascular events, quality of life, and other outcomes? … Mortality and major cardiovascular events? Low (ACE inhibitor vs. … BMC Cardiovascular Disorders 10 (#date#) 7 Schaer BA, Schneider C, Jick SS, et al.. 2010.

128. Self-Measured Blood Pressure: Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure-future_research.pdf
     August 01, 2012 - The benefits of long- term BP control are presumed to include a reduction in clinical cardiovascular … How do different metrics of aggregated SMBP readings predict risk for cardiovascular disease? … outcome of myocardial infarction, stroke, or death from cardiovascular causes. … factor (i.e., those without a history of cardiovascular disease) it was lower at 10 percent. … disease or diabetes would be expected to have lower risk of cardiovascular disease.

129. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
     November 01, 2010 - Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. … Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular … Cardiovascular outcomes and all- cause mortality: exploring the interaction between CKD and cardiovascular … Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. … Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

130. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-drugs-utilization/research
     December 01, 2019 - rosiglitazone, a thiazolidinedione, was found to be associated with myocardial infarction, major adverse cardiovascular … events, mortality from cardiovascular causes, and all-cause mortality. … Systematic Review Mar 03, 2025 Association of Digestible Carbohydrate Intake With Cardiovascular

131. Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m² | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/weight-loss-surgery/research
     December 01, 2019 - adverse effects, and we found no evidence regarding major clinical endpoints such as all-cause mortality, cardiovascular … Systematic Review Mar 03, 2025 Association of Digestible Carbohydrate Intake With Cardiovascular … Research Protocol Dec 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular

132. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
     March 29, 2016 - Commentator & Affiliation Section Comment Response Vinay Malhotra, MD, Society of Cardiovascular … Commentator & Affiliation Section Comment Response Vinay Malhotra, MD, Society of Cardiovascular … Commentator & Affiliation Section Comment Response Vinay Malhotra, MD, Society of Cardiovascular … Commentator & Affiliation Section Comment Response Vinay Malhotra, MD, Society of Cardiovascular … SCCT guidelines on radiation dose and doseoptimization strategies in cardiovascular CT.

133. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/renal-function/research
     December 01, 2019 - compared a cardiac troponin elevation with a nonelevation in terms of diagnostic accuracy, mortality, or cardiovascular … Elevated troponin was associated with all-cause and cardiovascular mortality among dialysis patients … pooled: All-cause mortality, troponin T (HR 3.0 [95% CI 2.4 to 4.3]), troponin I (HR 2.7 [1.9 to 4.6]); Cardiovascular

134. TND-555-09-03-2013 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
     January 01, 2013 - such as episodes of hypoglycemia, and complications including kidney disease, amputation, blindness, cardiovascular … Completion Date: 02-13-2013 3 Control and Complications Trial (DCCT) (as measured by retinal, renal, cardiovascular … A decrease in or prevention of diabetes-related complications (as measured by retinal, renal, cardiovascular

135. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
     April 06, 2010 -  All-cause mortality  Cardiovascular mortality  Cardiovascular and cerebrovascular morbidity (e.g … mortality • Cardiovascular and cerebrovascular morbidity (e.g., myocardial infarction and stroke) … Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. … Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis … □ For Key Question 2, we included the following outcomes: all-cause mortality, cardiovascular disease

136. Proposed Governance and Data Management Policy for the Systematic Review Data Repository | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/data-repository-reviews/white-paper
     January 01, 2019 - Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular … Research Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular

137. Comparative Effectiveness, Safety and Indications of Pre-mixed Insulin Analogues for Adults with Type 2 Diabetes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/type-2-diabetes-insulin/research
     December 01, 2019 - Systematic Review Mar 03, 2025 Association of Digestible Carbohydrate Intake With Cardiovascular … Research Protocol Dec 21, 2023 The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular

138. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
     June 01, 2011 - angiotensin II receptor antagonists), and direct renin inhibitorsb differ in blood pressure control, cardiovascular … risk reduction, cardiovascular events, quality of life, and other outcomesc? … Due to low numbers of deaths or major cardiovascular cardiovascular events? … In particular, there is a lack of information about death or major cardiovascular events, and inconsistently … disease-specific, and cerebrovascular disease-specific). • Morbidity (especially major cardiovascular

139. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - disease and worse cardiovascular risk factors. … Cardiovascular outcomes Only Webster 1998 (SNRASCG) reported on cardiovascular outcomes.12 The study … The most common cause of mortality reported was due to cardiovascular-related deaths. … Cardiovascular outcomes Only three studies reported cardiovascular event rates, including one of the … Increased cardiovascular mortality in hypertensive patients with renal artery stenosis.

140. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
     November 22, 2011 - CVD is the leading cause of death in the United States, with cardiovascular mortality accounting for … The total number of inpatient cardiovascular operations and procedures was approximately 7 million … Eligibility criteria  Populations—for all Key Questions Adult patients with cardiovascular, … Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. … Clopidogrel non- responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.